Kurs & Likviditet
Kalender
2024-10-29 | Kvartalsrapport 2024-Q3 |
2024-10-15 | X-dag halvårsutdelning ORNBV 0.81 |
2024-10-15 | X-dag halvårsutdelning ORNAV 0.81 |
2024-08-08 | Kvartalsrapport 2024-Q2 |
2024-04-25 | Kvartalsrapport 2024-Q1 |
2024-03-21 | X-dag halvårsutdelning ORNAV 0.81 |
2024-03-21 | X-dag halvårsutdelning ORNBV 0.81 |
2024-03-20 | Årsstämma 2024 |
2024-02-13 | Bokslutskommuniké 2023 |
2023-10-26 | Kvartalsrapport 2023-Q3 |
2023-07-17 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-03-23 | X-dag ordinarie utdelning ORNAV 1.60 EUR |
2023-03-23 | X-dag ordinarie utdelning ORNBV 1.60 EUR |
2023-03-22 | Årsstämma 2023 |
2023-02-09 | Bokslutskommuniké 2022 |
2022-10-20 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-03-24 | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2022-03-24 | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2022-03-23 | Årsstämma 2022 |
2022-02-10 | Bokslutskommuniké 2021 |
2021-10-20 | Kvartalsrapport 2021-Q3 |
2021-07-19 | Kvartalsrapport 2021-Q2 |
2021-04-27 | Kvartalsrapport 2021-Q1 |
2021-03-26 | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2021-03-26 | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2021-03-25 | Årsstämma 2021 |
2021-02-09 | Bokslutskommuniké 2020 |
2020-10-21 | Kvartalsrapport 2020-Q3 |
2020-07-17 | Kvartalsrapport 2020-Q2 |
2020-05-07 | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2020-05-07 | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2020-05-06 | Årsstämma 2020 |
2020-04-28 | Kvartalsrapport 2020-Q1 |
2020-03-26 | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2020-02-05 | Bokslutskommuniké 2019 |
2019-10-23 | Kvartalsrapport 2019-Q3 |
2019-07-17 | Kvartalsrapport 2019-Q2 |
2019-04-25 | Kvartalsrapport 2019-Q1 |
2019-03-27 | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2019-03-27 | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2019-03-26 | Årsstämma 2019 |
2019-02-06 | Bokslutskommuniké 2018 |
2018-10-24 | Kvartalsrapport 2018-Q3 |
2018-07-18 | Kvartalsrapport 2018-Q2 |
2018-04-24 | Kvartalsrapport 2018-Q1 |
2018-03-21 | X-dag ordinarie utdelning ORNBV 1.45 EUR |
2018-03-21 | X-dag ordinarie utdelning ORNAV 1.45 EUR |
2018-03-20 | Årsstämma 2018 |
2018-02-07 | Bokslutskommuniké 2017 |
2017-10-26 | Kvartalsrapport 2017-Q3 |
2017-07-19 | Kvartalsrapport 2017-Q2 |
2017-05-18 | Kapitalmarknadsdag 2017 |
2017-04-26 | Kvartalsrapport 2017-Q1 |
2017-03-23 | X-dag bonusutdelning ORNBV 0.2 |
2017-03-23 | X-dag ordinarie utdelning ORNAV 1.35 EUR |
2017-03-23 | X-dag bonusutdelning ORNAV 0.2 |
2017-03-23 | X-dag ordinarie utdelning ORNBV 1.35 EUR |
2017-03-22 | Årsstämma 2017 |
2017-02-08 | Bokslutskommuniké 2016 |
2016-10-25 | Kvartalsrapport 2016-Q3 |
2016-07-19 | Kvartalsrapport 2016-Q2 |
2016-04-27 | Kvartalsrapport 2016-Q1 |
2016-03-23 | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2016-03-23 | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2016-03-22 | Årsstämma 2016 |
2016-02-02 | Bokslutskommuniké 2015 |
2015-10-27 | Kvartalsrapport 2015-Q3 |
2015-07-28 | Kvartalsrapport 2015-Q2 |
2015-05-26 | Kapitalmarknadsdag 2015 |
2015-04-29 | Kvartalsrapport 2015-Q1 |
2015-03-25 | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2015-03-25 | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2015-03-24 | Årsstämma 2015 |
2015-02-04 | Bokslutskommuniké 2014 |
2014-10-21 | Kvartalsrapport 2014-Q3 |
2014-07-29 | Kvartalsrapport 2014-Q2 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-03-26 | X-dag ordinarie utdelning ORNBV 1.25 EUR |
2014-03-26 | X-dag ordinarie utdelning ORNAV 1.25 EUR |
2014-03-25 | Årsstämma 2014 |
2014-02-04 | Bokslutskommuniké 2013 |
2013-10-22 | Kvartalsrapport 2013-Q3 |
2013-07-30 | Kvartalsrapport 2013-Q2 |
2013-04-23 | Kvartalsrapport 2013-Q1 |
2013-03-20 | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2013-03-20 | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2013-03-19 | Årsstämma 2013 |
2013-02-05 | Bokslutskommuniké 2012 |
2012-10-23 | Kvartalsrapport 2012-Q3 |
2012-07-31 | Kvartalsrapport 2012-Q2 |
2012-05-24 | Kapitalmarknadsdag 2012 |
2012-04-24 | Kvartalsrapport 2012-Q1 |
2012-03-21 | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2012-03-21 | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2012-03-21 | X-dag bonusutdelning ORNAV 0.12 |
2012-03-21 | X-dag bonusutdelning ORNBV 0.12 |
2012-03-20 | Årsstämma 2012 |
2012-02-07 | Bokslutskommuniké 2011 |
2011-10-25 | Kvartalsrapport 2011-Q3 |
2011-08-02 | Kvartalsrapport 2011-Q2 |
2011-04-27 | Kvartalsrapport 2011-Q1 |
2011-04-01 | X-dag bonusutdelning ORNAV 0.06 |
2011-04-01 | X-dag ordinarie utdelning ORNAV 1.20 EUR |
2011-04-01 | X-dag ordinarie utdelning ORNBV 1.20 EUR |
2011-04-01 | X-dag bonusutdelning ORNBV 0.06 |
2011-03-31 | Årsstämma 2011 |
2011-02-09 | Bokslutskommuniké 2010 |
2010-10-26 | Kvartalsrapport 2010-Q3 |
2010-08-10 | Kvartalsrapport 2010-Q2 |
2010-04-27 | Kvartalsrapport 2010-Q1 |
2010-03-25 | X-dag bonusutdelning ORNBV 0.1 |
2010-03-25 | X-dag ordinarie utdelning ORNBV 1.00 EUR |
2010-03-25 | X-dag ordinarie utdelning ORNAV 1.00 EUR |
2010-03-25 | X-dag bonusutdelning ORNAV 0.1 |
2009-03-24 | X-dag ordinarie utdelning ORNBV 0.95 EUR |
2009-03-24 | X-dag ordinarie utdelning ORNAV 0.95 EUR |
2008-03-26 | X-dag ordinarie utdelning ORNBV 1.00 EUR |
2007-04-03 | X-dag ordinarie utdelning ORNAV 1.00 EUR |
2007-04-03 | X-dag ordinarie utdelning ORNBV 1.00 EUR |
2006-03-22 | X-dag ordinarie utdelning ORNBV 0.85 EUR |
2005-03-22 | X-dag ordinarie utdelning ORNAV 0.55 EUR |
2005-03-22 | X-dag ordinarie utdelning ORNBV 0.55 EUR |
2004-09-15 | X-dag bonusutdelning ORNBV 2.14 |
2004-09-15 | X-dag bonusutdelning ORNAV 2.14 |
2004-03-23 | X-dag ordinarie utdelning ORNAV 1.60 EUR |
2004-03-23 | X-dag ordinarie utdelning ORNBV 1.60 EUR |
2003-12-12 | X-dag bonusutdelning ORNBV 1.5 |
2003-12-12 | X-dag bonusutdelning ORNAV 1.5 |
2003-03-23 | X-dag ordinarie utdelning ORNAV 0.93 EUR |
2003-03-23 | X-dag ordinarie utdelning ORNBV 0.93 EUR |
2002-04-16 | X-dag ordinarie utdelning ORNAV 1.10 EUR |
2002-04-16 | X-dag ordinarie utdelning ORNBV 1.10 EUR |
2001-03-30 | X-dag ordinarie utdelning ORNAV 1.20 EUR |
2001-03-30 | X-dag ordinarie utdelning ORNBV 1.20 EUR |
2000-03-31 | X-dag ordinarie utdelning ORNBV 1.18 EUR |
2000-03-31 | X-dag ordinarie utdelning ORNAV 1.18 EUR |
1999-07-28 | X-dag bonusutdelning ORNBV 13.46 |
1999-07-28 | X-dag bonusutdelning ORNAV 13.46 |
1999-04-09 | X-dag ordinarie utdelning ORNAV 6.50 EUR |
1999-04-09 | X-dag ordinarie utdelning ORNBV 6.50 EUR |
1998-04-21 | X-dag ordinarie utdelning ORNBV 7.50 EUR |
1998-04-21 | X-dag ordinarie utdelning ORNAV 7.50 EUR |
1997-04-22 | X-dag ordinarie utdelning ORNBV 5.00 EUR |
1997-04-22 | X-dag ordinarie utdelning ORNAV 5.00 EUR |
1996-04-23 | X-dag ordinarie utdelning ORNAV 4.00 EUR |
1996-04-23 | X-dag ordinarie utdelning ORNBV 4.00 EUR |
Beskrivning
Land | Finland |
---|---|
Lista | Large Cap Helsinki |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
ORION CORPORATION
STOCK EXCHANGE RELEASE – INSIDE INFORMATION
1 JULY 2024 at 15:15 EEST
Inside information: Orion upgrades full-year outlook for 2024
Orion Corporation upgrades the full-year outlook for 2024 both for the part regarding net sales and operating profit. Orion and MSD (Merck & Co., Inc., Rahway, NJ, USA) have exercised the option to convert the co-development and co-commercialisation agreement with MSD regarding opevesostat (MK-5684/ODM-208), an investigational CYP11A1 inhibitor, and other candidates targeting CYP11A1 into an exclusive global license for MSD. As a consequence of this decision, Orion announced it will release from the balance sheet the EUR 60 million item reserved to cover Orion’s share of accrued R&D costs related to the co-development. The item will have positive impact on both Orion’s net sales and operating profit in the third quarter of 2024. For this reason, Orion upgrades full-year outlook for 2024.
It is further noted that all of our businesses have developed positively during the first half of the year.
New full-year outlook, provided on 1 July 2024
Net sales are estimated to be EUR 1,440 million to EUR 1,480 million.
Operating profit is estimated to be EUR 350 million to EUR 380 million.
Previous full-year outlook, provided on 13 February and specified on 24 April 2024
Net sales are estimated to be EUR 1,340 million to EUR 1,410 million.
Operating profit is estimated to be EUR 280 million to EUR 310 million.
Orion Corporation
Liisa Hurme President and CEO | Olli Huotari SVP, Corporate Functions |
Contact person:
Tuukka Hirvonen, Investor Relations, Orion Corporation
tel. +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.